Corgentech is a biopharmaceutical company
focused on the development and commercialization of
DNA-based novel therapeutics for significant unmet medical
needs. We are creating a pipeline of novel therapeutics
focused initially on the treatment of inflammatory diseases,
infectious diseases and cancer. For more information on the
company and its technologies, please visit
www.corgentech.com.
